One study found that oxidatively modified cytoplasmic protein disulfide bond isomerase 3 (PDIA3) in HCC promoted DKC1-mediated survival of HCC and that DKC1 is a worthwhile target for HCC prediction and treatment (Ko et al., 2018). This evidence concerns the gene PDIA3 and hepatocellular carcinoma.